Back to top

Piper Sandler Sticks to Its Buy Rating for GeneDx Holdings (WGS)

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on GeneDx Holdings, with a price target of $63.00. Westenbe...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GeneDx Holdings Corp. (WGS)